Contact us

Support


Home > Investment tools > They choose Russia > AVVA Pharmaceuticals

AVVA Pharmaceuticals

The pharmaceutical company Avva Rus, a subsidiary of Swiss AVVA Pharmaceuticals, intends to build a plant for the production of pharmaceutical substances in Slobodino industrial park (the Kirov Region). The project is estimated at 100 million rubles. "The company plans to implement a project aimed at import substitution of active pharmaceutical substances based on materials of animal and plant origin. The project involves the development of technology and the organization of the substance production,"- Alexei Egorov, Director General of Avva Rus said to Vademecum.

The company expects to invest up to 100 million rubles in the project by investing approximately fifty-fifty of borrowed and own funds, explained the Director General.

05 April 2018
https://vademec.ru/
Investor
1.7 mln
Kirov Region

Investor profile

AVVA Pharmaceuticals

Switzerland

Company's website: https://www.avvapharma.com/about-us/

T: +357 25 572 200

Private company

E-mail: info@avvapharma.com

The company - manufacturer of innovative medicines

Subscribe to Newsletters

Email: